AUTL

Autolus Therapeutics
AUTL

Overview Fund Trends Analyst Outlook Journalist POV

38 hedge funds and large institutions have $558M invested in Autolus Therapeutics in 2018 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 18 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10: →

more capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

less funds holding

Funds holding: →

3.71% less ownership

Funds ownership: 46.02% → 42.31% (-3.7%)

67% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 18

Holders
38
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$36.1M
2
+$6.5M
3
+$3.96M
4
TAM
TFG Asset Management
Cayman Islands
+$323K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$322K

Top Sellers

1
-$40.7M
2
-$6.74M
3
-$4.73M
4
SFM
Sphera Funds Management
Israel
-$3.06M
5
BBA
Baker Bros. Advisors
New York
-$2.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$312K
27
$263K
28
$224K
29
$220K
30
$201K
31
$113K
32
$31K
33
$29K
34
$18K
35
$13K
36
$7K
37
$2K
38
$1K
39
–
40
–
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2